{
    "nctId": "NCT00015886",
    "briefTitle": "Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery",
    "officialTitle": "Docetaxel (Taxotere) and 5-Fluorouracil As Second- Or Third-Line Chemotherapy In Women With Metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "To determine the response rate to this combination after two to four courses of Docetaxel (Taxotere) And 5-Fluorouracil",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Histologically confirmed breast cancer\n\n  * Metastatic or unresectable local disease\n* Measurable or evaluable disease\n* No ascites or pleural effusion as only metastatic site\n* No brain or leptomeningeal metastases\n* Hormone receptor status:\n\n  * Not specified\n\nPATIENT CHARACTERISTICS:\n\nAge:\n\n* 18 and over\n\nSex:\n\n* Female\n\nMenopausal status:\n\n* Not specified\n\nPerformance status:\n\n* 0-2\n\nLife expectancy:\n\n* At least 3 months\n\nHematopoietic:\n\n* Granulocyte count greater than 1,500/mm3\n* Platelet count greater than 100,000/mm3\n\nHepatic:\n\n* Bilirubin normal\n* SGOT/SGPT less than 1.5 times upper limit of normal (ULN)\n* Alkaline phosphatase less than 2.5 times ULN\n\nRenal:\n\n* Creatinine no greater than 2 times ULN\n\nCardiovascular:\n\n* Adequate cardiac function\n* No history of significant atherosclerotic coronary disease (e.g., uncontrolled angina)\n* No history of significant cardiac arrhythmia\n\nOther:\n\n* No serious medical or psychiatric illness that would preclude study\n* No active uncontrolled bacterial, viral, or fungal infection\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception\n\nPRIOR CONCURRENT THERAPY:\n\nBiologic therapy:\n\n* No prior high-dose chemotherapy and autologous transplantation\n\nChemotherapy:\n\n* At least 3 weeks since prior chemotherapy and recovered\n* No more than 2 prior chemotherapy regimens for metastatic breast cancer (in addition to adjuvant therapy)\n* No prior docetaxel\n* No prior high-dose chemotherapy and autologous transplantation\n* Prior paclitaxel allowed\n\nEndocrine therapy:\n\n* No concurrent hormonal therapy, except as contraception\n\nRadiotherapy:\n\n* At least 3 weeks since prior radiotherapy and recovered\n* Concurrent radiotherapy for relief of localized pain or obstruction allowed\n\nSurgery:\n\n* At least 2 weeks since prior major surgery and recovered\n\nOther:\n\n* No other concurrent cytotoxic agents",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}